Rheumatoid Arthritis Clinical Trial
Official title:
H215O Positron Emission Tomography (PET) in the Assessment of Synovial Blood Flow in Rheumatoid Arthritis Patients
This study will test whether positron emission tomography (PET) imaging can be used to
measure blood flow to joints in patients with rheumatoid arthritis (RA). It will also
compare blood flow measurements using PET with measurements obtained with magnetic resonance
imaging (MRI) to determine how useful MRI is in measuring blood flow to joints.
Much of the joint damage in RA is caused by the synovium-the lining of the joint. In RA, the
synovium increases in size and destroys bone and cartilage. The synovium maintains its
growth by forming many new small blood vessels to nourish it. New drug treatments are being
developed to stop the growth of these new blood vessels. The effect of these treatments on
the synovium is usually measured by performing a biopsy-removing a small piece of synovium
for examination under a microscope. The biopsy requires inserting a needle into the joint to
withdraw the synovial tissue. This study will see if changes in blood flow can be assessed
accurately using noninvasive imaging procedures, such as PET scanning, instead of a biopsy.
Patients 18 years of age and older with rheumatoid arthritis who have at least one tender
and swollen knee due to synovitis may be eligible for this study. Candidates will be
screened with a medical history and physical examination.
Participants will have a mold made of the knee to be studied and will have routine blood
tests. Women who are able to become pregnant will have a pregnancy test. All participants
will then undergo PET and MRI scanning as described below:
PET - A needle is used to insert a catheter (small plastic tube) into an arm vein for
injection of the radioactive substance H215O. The patient lies in a doughnut-shaped machine
(the PET scanner) and a quick scan is done to measure body thickness. Then, a separate scan
is taken following each of six or fewer injections of H215O. Each scan lasts about 13
minutes.
MRI - The patient lies on a stretcher that is moved into a cylinder containing a magnetic
field (the MRI scanner). A special coil is placed over the knee to improve the quality of
the images. Earplugs are worn to muffle the loud thumping sound produced by electrical
switching of the magnetic fields during the imaging. A contrast agent called gadolinium is
injected through a catheter into a vein to improve the quality of the images. An intercom
system permits the patient to communicate with the technician at all times during the
procedure.
Because of the proliferative nature of rheumatoid synovial tissue, many new pharmaceuticals
are targeting angiogenesis inhibition as a means of halting synovial growth. Although
clinical markers of rheumatoid arthritis (RA) activity may function as surrogate endpoints
in trials of these new agents, a non-invasive technique of assessing synovial blood flow
would be the ideal outcome measure.
PET imaging has been used to quantify blood flow to a variety of tissues, with significant
experience at this institution in the area of tumor blood flow analysis.
The objective of this study is to evaluate the feasibility of H2 (15)O PET for the
measurement of synovial blood flow in patients with RA. In 10 RA patients with active knee
synovitis, clinical and radiological (H2 (15)O PET and dynamic MRI) evaluation will be
performed. The feasibility of H2 (15)O PET will be evaluated by its reproducibility. We will
also evaluate the correlation of dynamic MRI with synovial blood flow measurement by H2
(15)O PET.
;
Endpoint Classification: Safety Study, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04226131 -
MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics
|
N/A | |
Completed |
NCT04171414 -
A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT02833350 -
Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA)
|
Phase 2 | |
Completed |
NCT04255134 -
Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN)
|
Phase 4 | |
Recruiting |
NCT05615246 -
Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
|
||
Completed |
NCT03248518 -
Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases
|
N/A | |
Completed |
NCT03514355 -
MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms
|
N/A | |
Recruiting |
NCT06005220 -
SBD121, a Synbiotic Medical Food for RA Management
|
N/A | |
Recruiting |
NCT05451615 -
Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT05054920 -
Eccentric Versus Concentric Exercises for Rotator Cuff Tendinopathy in Patients With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT02037737 -
Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting
|
N/A | |
Recruiting |
NCT04079374 -
Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel
|
Phase 3 | |
Completed |
NCT02504268 -
Effects of Abatacept in Patients With Early Rheumatoid Arthritis
|
Phase 3 | |
Recruiting |
NCT05496855 -
Remote Care in People With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT05051943 -
A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
|
||
Recruiting |
NCT06103773 -
A Study of Single and Multiple Oral Doses of TollB-001
|
Phase 1 | |
Recruiting |
NCT06031415 -
Study of GS-0272 in Participants With Rheumatoid Arthritis
|
Phase 1 | |
Completed |
NCT05999266 -
The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
|
||
Recruiting |
NCT05302934 -
Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
|
||
Recruiting |
NCT04169100 -
Novel Form of Acquired Long QT Syndrome
|
Phase 4 |